{"id":"W3162915930","doi":"10.1016/j.msard.2021.103012","title":"The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cegep de Saint Jerome; Université de Montréal; Hôpital Notre-Dame; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"National Health and Medical Research Council; Centre Hospitalier Universitaire de Rennes; Sanofi Genzyme; Multiple Sclerosis Society; Centre Hospitalier Universitaire de Nice; Sanofi; Université Claude Bernard Lyon 1; Institut National de la Santé et de la Recherche Médicale; Canadian Institutes of Health Research; Centre Hospitalier Universitaire de Toulouse; Multiple Sclerosis Society of Canada; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Novartis; Celgene; Fondazione Italiana Sclerosi Multipla; Biogen; MedDay Pharmaceuticals; GlaxoSmithKline; Merck; Teva Pharmaceutical Industries; Université de Lorraine; Centre Hospitalier Universitaire de Bordeaux; Hospices Civils de Lyon; Agence Nationale de la Recherche; Roche","keywords":"Fingolimod; Natalizumab; Medicine; Multiple sclerosis; Hazard ratio; Internal medicine; Immunology; Confidence interval","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006579405,0.0001774161,0.0006011491,0.0000830592,0.0002509673,0.00001979114,0.0001587595,0.00011693,0.00001575114],"category_scores_gemma":[0.004179392,0.0001199606,0.0001860234,0.0003170019,0.0008526454,0.00006278203,0.0002905669,0.0002769799,0.000001798324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005695748,"about_ca_system_score_gemma":0.00007083127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001192107,"about_ca_topic_score_gemma":0.0001277929,"domain_scores_codex":[0.9981081,0.0002820084,0.000549268,0.0003230165,0.0004897536,0.000247782],"domain_scores_gemma":[0.9966742,0.002106524,0.0002239821,0.000376209,0.0005460135,0.00007309936],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003084579,0.001074271,0.8333111,0.001560646,0.004216113,0.000005503377,0.002875626,0.0004093745,0.1046749,0.0006929745,0.001102973,0.04699187],"study_design_scores_gemma":[0.006220549,0.0002536659,0.945301,0.001578316,0.0001282967,0.000005591298,0.007342516,0.002798616,0.03441407,0.0001603393,0.00163874,0.0001582886],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.970509,0.02591199,0.00002382652,0.001207066,0.0003763656,0.0004174495,0.00003835917,0.00002763016,0.001488349],"genre_scores_gemma":[0.961756,0.03782242,0.0001567141,0.000009830348,0.00001562864,0.00004220721,0.00003327879,0.00001838467,0.0001455217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1119898,"threshold_uncertainty_score":0.5003425,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04998136824734042,"score_gpt":0.3325948420056046,"score_spread":0.2826134737582642,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}